In vivo administration of interferon γ does not cause marrow aplasia in mice with a targeted disruption of FANCC

Peter Kurre, Ponni Anandakumar, Markus Grompe, Hans Peter Kiem

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective. Hematopoietic cells from patients with Fanconi anemia (FA) and mice carrying a targeted disruption of the gene encoding complementation group C protein (FANCC-/-) demonstrate an apoptotic phenotype in response to alkylating agents and cytokines including interferon γ (IFN-γ) in vitro. The aim of this study was to explore these apoptosis-inducing effects of IFN-γ on the bone marrow of FANCC-/- mice as a potential strategy to select gene-corrected cells in vivo. Materials and Methods. Following pharmacokinetic studies to determine if serum concentrations effective in vitro can be achieved in vivo, we injected FANCC-/- mice with recombinant murine IFN-γ. Hematopoietic effects were investigated by serial determinations of blood counts, progenitor colony formation, and marrow cellularity. Results. Serial weekly intraperitoneal administrations of escalating doses of rmIFN-γ did not affect peripheral blood counts in FANCC-/- mice, even after subsequent antibody-mediated fas ligation. Additionally, prolonged exposure after sequential daily administration of recombinant IFN-γ did not impair progenitor cell clonogenicity in vitro. Pharmacokinetic data confirmed that the failure of IFN-γ to induce marrow aplasia occurred in spite of peak serum levels greater than 100-fold in excess of those effective in vitro. Conclusion. We conclude that in spite of the well-documented in vitro apoptotic tendency of FA-phenotype hematopoietic cells, the in vivo administration of IFN-γ with and without subsequent fas ligation does not induce bone marrow failure in FANCC-/- (129SvJ strain) mice. Additional selective pressure may be necessary to achieve targeted ablation of uncorrected, FA-phenotype, marrow cells.

Original languageEnglish (US)
Pages (from-to)1257-1262
Number of pages6
JournalExperimental Hematology
Volume30
Issue number11
DOIs
StatePublished - Nov 1 2002

Fingerprint

Interferons
Bone Marrow
Fanconi Anemia
Phenotype
Fanconi Anemia Complementation Group C Protein
Ligation
Pharmacokinetics
Alkylating Agents
Protein C
Serum
Genes
Stem Cells
In Vitro Techniques
Apoptosis
Cytokines
Antibodies

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

In vivo administration of interferon γ does not cause marrow aplasia in mice with a targeted disruption of FANCC. / Kurre, Peter; Anandakumar, Ponni; Grompe, Markus; Kiem, Hans Peter.

In: Experimental Hematology, Vol. 30, No. 11, 01.11.2002, p. 1257-1262.

Research output: Contribution to journalArticle

@article{54dd75b31467402698e93acc0e2a9724,
title = "In vivo administration of interferon γ does not cause marrow aplasia in mice with a targeted disruption of FANCC",
abstract = "Objective. Hematopoietic cells from patients with Fanconi anemia (FA) and mice carrying a targeted disruption of the gene encoding complementation group C protein (FANCC-/-) demonstrate an apoptotic phenotype in response to alkylating agents and cytokines including interferon γ (IFN-γ) in vitro. The aim of this study was to explore these apoptosis-inducing effects of IFN-γ on the bone marrow of FANCC-/- mice as a potential strategy to select gene-corrected cells in vivo. Materials and Methods. Following pharmacokinetic studies to determine if serum concentrations effective in vitro can be achieved in vivo, we injected FANCC-/- mice with recombinant murine IFN-γ. Hematopoietic effects were investigated by serial determinations of blood counts, progenitor colony formation, and marrow cellularity. Results. Serial weekly intraperitoneal administrations of escalating doses of rmIFN-γ did not affect peripheral blood counts in FANCC-/- mice, even after subsequent antibody-mediated fas ligation. Additionally, prolonged exposure after sequential daily administration of recombinant IFN-γ did not impair progenitor cell clonogenicity in vitro. Pharmacokinetic data confirmed that the failure of IFN-γ to induce marrow aplasia occurred in spite of peak serum levels greater than 100-fold in excess of those effective in vitro. Conclusion. We conclude that in spite of the well-documented in vitro apoptotic tendency of FA-phenotype hematopoietic cells, the in vivo administration of IFN-γ with and without subsequent fas ligation does not induce bone marrow failure in FANCC-/- (129SvJ strain) mice. Additional selective pressure may be necessary to achieve targeted ablation of uncorrected, FA-phenotype, marrow cells.",
author = "Peter Kurre and Ponni Anandakumar and Markus Grompe and Kiem, {Hans Peter}",
year = "2002",
month = "11",
day = "1",
doi = "10.1016/S0301-472X(02)00932-3",
language = "English (US)",
volume = "30",
pages = "1257--1262",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - In vivo administration of interferon γ does not cause marrow aplasia in mice with a targeted disruption of FANCC

AU - Kurre, Peter

AU - Anandakumar, Ponni

AU - Grompe, Markus

AU - Kiem, Hans Peter

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Objective. Hematopoietic cells from patients with Fanconi anemia (FA) and mice carrying a targeted disruption of the gene encoding complementation group C protein (FANCC-/-) demonstrate an apoptotic phenotype in response to alkylating agents and cytokines including interferon γ (IFN-γ) in vitro. The aim of this study was to explore these apoptosis-inducing effects of IFN-γ on the bone marrow of FANCC-/- mice as a potential strategy to select gene-corrected cells in vivo. Materials and Methods. Following pharmacokinetic studies to determine if serum concentrations effective in vitro can be achieved in vivo, we injected FANCC-/- mice with recombinant murine IFN-γ. Hematopoietic effects were investigated by serial determinations of blood counts, progenitor colony formation, and marrow cellularity. Results. Serial weekly intraperitoneal administrations of escalating doses of rmIFN-γ did not affect peripheral blood counts in FANCC-/- mice, even after subsequent antibody-mediated fas ligation. Additionally, prolonged exposure after sequential daily administration of recombinant IFN-γ did not impair progenitor cell clonogenicity in vitro. Pharmacokinetic data confirmed that the failure of IFN-γ to induce marrow aplasia occurred in spite of peak serum levels greater than 100-fold in excess of those effective in vitro. Conclusion. We conclude that in spite of the well-documented in vitro apoptotic tendency of FA-phenotype hematopoietic cells, the in vivo administration of IFN-γ with and without subsequent fas ligation does not induce bone marrow failure in FANCC-/- (129SvJ strain) mice. Additional selective pressure may be necessary to achieve targeted ablation of uncorrected, FA-phenotype, marrow cells.

AB - Objective. Hematopoietic cells from patients with Fanconi anemia (FA) and mice carrying a targeted disruption of the gene encoding complementation group C protein (FANCC-/-) demonstrate an apoptotic phenotype in response to alkylating agents and cytokines including interferon γ (IFN-γ) in vitro. The aim of this study was to explore these apoptosis-inducing effects of IFN-γ on the bone marrow of FANCC-/- mice as a potential strategy to select gene-corrected cells in vivo. Materials and Methods. Following pharmacokinetic studies to determine if serum concentrations effective in vitro can be achieved in vivo, we injected FANCC-/- mice with recombinant murine IFN-γ. Hematopoietic effects were investigated by serial determinations of blood counts, progenitor colony formation, and marrow cellularity. Results. Serial weekly intraperitoneal administrations of escalating doses of rmIFN-γ did not affect peripheral blood counts in FANCC-/- mice, even after subsequent antibody-mediated fas ligation. Additionally, prolonged exposure after sequential daily administration of recombinant IFN-γ did not impair progenitor cell clonogenicity in vitro. Pharmacokinetic data confirmed that the failure of IFN-γ to induce marrow aplasia occurred in spite of peak serum levels greater than 100-fold in excess of those effective in vitro. Conclusion. We conclude that in spite of the well-documented in vitro apoptotic tendency of FA-phenotype hematopoietic cells, the in vivo administration of IFN-γ with and without subsequent fas ligation does not induce bone marrow failure in FANCC-/- (129SvJ strain) mice. Additional selective pressure may be necessary to achieve targeted ablation of uncorrected, FA-phenotype, marrow cells.

UR - http://www.scopus.com/inward/record.url?scp=0036840671&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036840671&partnerID=8YFLogxK

U2 - 10.1016/S0301-472X(02)00932-3

DO - 10.1016/S0301-472X(02)00932-3

M3 - Article

C2 - 12423678

AN - SCOPUS:0036840671

VL - 30

SP - 1257

EP - 1262

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 11

ER -